GeneDx Holdings Corp. (WGS)
48.43
+1.14
(+2.41%)
USD |
NASDAQ |
Nov 18, 10:12
GeneDx Holdings Enterprise Value : 1.462B for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.462B |
| November 16, 2026 | 1.574B |
| November 13, 2026 | 1.614B |
| November 12, 2026 | 1.599B |
| November 11, 2026 | 1.696B |
| November 10, 2026 | 1.688B |
| November 09, 2026 | 2.014B |
| November 06, 2026 | 1.914B |
| November 05, 2026 | 1.973B |
| November 04, 2026 | 2.122B |
| November 03, 2026 | 2.101B |
| November 02, 2026 | 1.965B |
| October 30, 2026 | 2.114B |
| October 29, 2026 | 2.173B |
| October 28, 2026 | 1.983B |
| October 27, 2026 | 1.925B |
| October 26, 2026 | 1.880B |
| October 23, 2026 | 1.727B |
| October 22, 2026 | 2.056B |
| October 21, 2026 | 2.110B |
| October 20, 2026 | 2.104B |
| October 19, 2026 | 2.031B |
| October 16, 2026 | 1.951B |
| October 15, 2026 | 2.149B |
| October 14, 2026 | 2.100B |
| Date | Value |
|---|---|
| October 13, 2026 | 1.991B |
| October 12, 2026 | 1.957B |
| October 09, 2026 | 2.062B |
| October 08, 2026 | 2.074B |
| October 07, 2026 | 2.098B |
| October 06, 2026 | 2.188B |
| October 05, 2026 | 2.330B |
| October 02, 2026 | 2.235B |
| October 01, 2026 | 2.171B |
| September 30, 2026 | 2.211B |
| September 29, 2026 | 2.294B |
| September 28, 2026 | 2.596B |
| September 25, 2026 | 2.669B |
| September 24, 2026 | 2.672B |
| September 23, 2026 | 2.574B |
| September 22, 2026 | 2.741B |
| September 21, 2026 | 2.951B |
| September 18, 2026 | 3.048B |
| September 17, 2026 | 3.163B |
| September 16, 2026 | 2.938B |
| September 15, 2026 | 2.855B |
| September 14, 2026 | 2.709B |
| September 11, 2026 | 2.576B |
| September 10, 2026 | 2.537B |
| September 09, 2026 | 2.612B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CS Diagnostics Corp. | -- |
| Aibotics, Inc. | 3.405M |
| Twist Bioscience Corp. | 7.108B |
| Beam Therapeutics, Inc. | 1.336B |
| Ayujoy Herbals Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.33M |
| Revenue (Quarterly) | 123.10M |
| Total Expenses (Quarterly) | 135.43M |
| EPS Diluted (Quarterly) | -0.4126 |
| Gross Profit Margin (Quarterly) | 68.63% |
| Profit Margin (Quarterly) | -10.01% |
| Earnings Yield | -7.80% |
| Normalized Earnings Yield | -5.819 |